Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyuki Ujiie

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Journal of Dermatological Science|January 25, 2023
Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in JapanHideyuki Ujiie, Makoto Arakawa, Yumi Aoyama
Dermatologic Clinics|May 25, 2011
Pathogenesis of bullous pemphigoidHideyuki Ujiie, Wataru Nishie, Hiroshi Shimizu
Frontiers in Medicine|January 6, 2022
TRIM29 in Cutaneous Squamous Cell CarcinomaChe-Yuan Hsu, Teruki Yanagi, Hideyuki Ujiie
Genes|August 29, 2024
RETRACTED: Kosumi et al. Systemic Retinoids for Generalized Verrucosis Due to Congenital Immunodeficiency: Case Reports and Review of the Literature. <i>Genes</i> 2023, <i>14</i>, 769Hideyuki Kosumi, Ken Natsuga, Teruki Yanagi, et al.
Frontiers in Immunology|August 25, 2022
The significance of preclinical anti-BP180 autoantibodiesYosuke Mai, Kentaro Izumi, Shoko Mai, et al.
The Journal of Dermatology|October 26, 2024
A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single-center retrospective observational studySho Katayama, Kentaro Izumi, Inkin Ujiie, et al.
The Journal of Dermatology|May 29, 2010
What's new in bullous pemphigoidHideyuki Ujiie, Akihiko Shibaki, Wataru Nishie, et al.
Genes|March 29, 2023
Systemic Retinoids for Generalized Verrucosis Due to Congenital Immunodeficiency: Case Reports and Review of the LiteratureHideyuki Kosumi, Ken Natsuga, Teruki Yanagi, et al.
Cureus|July 29, 2025
Fatal Toxic Megacolon Following Nivolumab and Ipilimumab Therapy in Metastatic Melanoma: A Case ReportHibiki Fujiwara, Takuya Maeda, Takehiko Katsurada, et al.
The Journal of Dermatology|December 9, 2021
Efficacy of a combination of paclitaxel and radiation therapy against cutaneous angiosarcoma: A single-institution retrospective study of 21 casesTakashi Seo, Shinya Kitamura, Teruki Yanagi, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Journal of Dermatological Science|January 25, 2023
Intravenous immunoglobulin in patients with bullous pemphigoid insufficient response to corticosteroids: Nationwide post-marketing surveillance in JapanHideyuki Ujiie, Makoto Arakawa, Yumi Aoyama
Dermatologic Clinics|May 25, 2011
Pathogenesis of bullous pemphigoidHideyuki Ujiie, Wataru Nishie, Hiroshi Shimizu
Frontiers in Medicine|January 6, 2022
TRIM29 in Cutaneous Squamous Cell CarcinomaChe-Yuan Hsu, Teruki Yanagi, Hideyuki Ujiie
Genes|August 29, 2024
RETRACTED: Kosumi et al. Systemic Retinoids for Generalized Verrucosis Due to Congenital Immunodeficiency: Case Reports and Review of the Literature. <i>Genes</i> 2023, <i>14</i>, 769Hideyuki Kosumi, Ken Natsuga, Teruki Yanagi, et al.
Frontiers in Immunology|August 25, 2022
The significance of preclinical anti-BP180 autoantibodiesYosuke Mai, Kentaro Izumi, Shoko Mai, et al.
The Journal of Dermatology|October 26, 2024
A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single-center retrospective observational studySho Katayama, Kentaro Izumi, Inkin Ujiie, et al.
The Journal of Dermatology|May 29, 2010
What's new in bullous pemphigoidHideyuki Ujiie, Akihiko Shibaki, Wataru Nishie, et al.
Genes|March 29, 2023
Systemic Retinoids for Generalized Verrucosis Due to Congenital Immunodeficiency: Case Reports and Review of the LiteratureHideyuki Kosumi, Ken Natsuga, Teruki Yanagi, et al.
Cureus|July 29, 2025
Fatal Toxic Megacolon Following Nivolumab and Ipilimumab Therapy in Metastatic Melanoma: A Case ReportHibiki Fujiwara, Takuya Maeda, Takehiko Katsurada, et al.
The Journal of Dermatology|December 9, 2021
Efficacy of a combination of paclitaxel and radiation therapy against cutaneous angiosarcoma: A single-institution retrospective study of 21 casesTakashi Seo, Shinya Kitamura, Teruki Yanagi, et al.
Pageof 11